Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Eight Oxford scientists are amongst 50 of the UK's world-leading researchers elected to join the prestigious Fellowship of the Academy of Medical Sciences this year.

The new Fellows have been selected for their outstanding contributions to advancing medical science, cutting edge research discoveries, and translating developments into benefits for patients and wider society. Many of the new Fellows have also made a contribution to medical science through outstanding leadership, public engagement and supporting the career advancement of junior trainees.

The new Fellows are:

Professor Colin Baigent, Director, MRC Population Health Research Unit, University of Oxford.

Professor Philip Bejon, Director, KEMRI Wellcome Trust Research Programme, and Professor of Tropical Medicine, University of Oxford.

Professor Sarah C Darby FRS, Professor of Medical Statistics, University of Oxford.

Professor Benjamin Davis FRS MAE, Professor of Chemical Biology, University of Oxford, for the development of molecular methods for direct reprogramming of complex biological molecules to elucidate and control biological function and mechanism in vitro and in vivo, beyond the limits of genetics.

Professor Helen McShane, Director, Oxford NIHR Biomedical Research Centre and Professor of Vaccinology, University of Oxford. Professor McShane leads a translational research group focussed on TB vaccine development. This spans early vaccine design and testing through to field efficacy testing in TB endemic countries. Current interests include aerosol delivery of vaccines and the development of a controlled human infection model for TB.

Professor Richard Price, Professor of Global Health and Senior Principal Research Fellow, Menzies School of Health Research, and Professor of Tropical Medicine, University of Oxford.

Professor Alison Simmons, Professor of Gastroenterology at the Nuffield Department of Medicine and MRC Human Immunology Unit. This honour recognizes her work on innate immunity and inflammatory bowel disease (IBD), a condition where immune dysregulation within the intestine leads to debilitating symptoms and morbidity. Research by Professor Simmons and her group has provided fundamental new insights into IBD pathogenesis.

Professor Ann (Sarah) Walker, Professor of Medical Statistics and Epidemiology, University of Oxford. Her research focusses on translating advances in genetic sequencing into microbiology services, and linking this pathogen sequence data to electronic health records for large-scale epidemiology.

Read more (University of Oxford website)

Read more about the new fellows within the Medical Sciences Division

MRC Weatherall Institute of Molecular Medicine (Professor Alison Simmons)

Nuffield Department of Population Health (Professor Colin Baigent & Professor Sarah C Darby FRS)

Centre for Tropical Medicine & Global Health (Professor Richard Price & Professor Philip Bejon)

Similar stories

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.

Reprogramming tumour cells using an antimalarial drug

General Research

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.